This week's View focuses on the coronavirus disease 2019 (COVID-19) resources on ACC.org, including a summary of a trial to assess the safety and efficacy of hydroxychloroquine as post-exposure prophylaxis for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and three articles on mortality in patients with COVID-19 across the United States, the patterns of viral polymerase chain reaction positivity and their correlations with seroconversion and disease severity, and the safety and effectiveness of the ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: COVID-19 Hub, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Nonstatins, Novel Agents, Statins, Acute Heart Failure, Heart Failure and Cardiac Biomarkers

Keywords: EaglesEyeView, COVID-19, ACC COVID-19 Podcast, Acute Kidney Injury, Ageusia, Angiotensin-Converting Enzyme Inhibitors, Ascorbic Acid, Azithromycin, Calcium Channel Blockers, Coronavirus, Coronavirus Infections, severe acute respiratory syndrome coronavirus 2, Cough, C-Reactive Protein, Critical Illness, Diarrhea, Fever, Health Personnel, Hospital Mortality, Hydroxychloroquine, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Influenza Vaccines, Inpatients, Interleukin-6, Interleukin-8, Peptidyl-Dipeptidase A, Personal Protective Equipment, Post-Exposure Prophylaxis, Primary Prevention, Public Health, Quarantine, Respiratory Distress Syndrome, Renal Insufficiency, Respiration, Artificial, Respiratory Insufficiency, Reverse Transcriptase Polymerase Chain Reaction, Risk Factors, Sepsis, Shock, Spike Glycoprotein, Coronavirus, Telemedicine, Treatment Outcome, Vaccination, Ventilation, Virology, Vitamin D, Vomiting, Dyslipidemias, Heart Failure

< Back to Listings